Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07328035

Remission in Adults With Severe Asthma in Thailand

Status
Recruiting
Phase
Study type
Observational
Enrollment
230 (estimated)
Sponsor
Thammasat University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to determine the prevalence of remission among adults with severe asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete questionnaires on asthma symptoms and undergo pulmonary function testing and a blood test once.

Detailed description

This study is a cross-sectional study. Thai patients aged 18 years or older with severe asthma are included in the study. Participants will complete two questionnaires about asthma control: the Global Initiative for Asthma (GINA) and the Asthma Control Test (ACT), and will perform spirometry, a fractional exhaled nitric oxide (FeNO) test, and blood eosinophil counts (BEC).

Conditions

Interventions

TypeNameDescription
OTHERGlobal Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnairesGINA and ACT are questionnaires used to assess the level of asthma control.
DIAGNOSTIC_TESTSpirometrySpirometry is a tool used to assess pulmonary function.
DIAGNOSTIC_TESTFractional exhaled nitric oxide (FeNO) testFeNO is a tool used to assess eosinophilic airway inflammation and asthma remission.
DIAGNOSTIC_TESTBlood eosinophil count (BEC)BEC is a tool used to assess eosinophilic inflammation and asthma remission.

Timeline

Start date
2026-01-01
Primary completion
2026-10-31
Completion
2026-12-31
First posted
2026-01-08
Last updated
2026-04-17

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT07328035. Inclusion in this directory is not an endorsement.